Avid Bioservices Inc (CDMO)

[co3aii]

What is at work is the probability of there being good NSCLC trial data that can be used to advance to a Phase III and with it validate Bavi. Unrecoverable therefore unusable data which invalidates Bavi would have been announced by now. IMHO what the market has begun to say is that as more time passes the likelihood of that conclusion is increasing. If the data had conclusively demonstrated that Bavi is not efficacious then we would have seen a announcement by now. Outright failure is a material event and must be announced immediately. Moreover given that PPHM is once again presenting at key conferences the news to come is more than likely good.

Keep in mind that whatever the argument over the K-M estimator charts we have seen there is separation and separation means efficacy. It appears that the market has decided that the time discount is now working in PPHM's favor.

In regard to those who do not think TA is at work: the $1.15 resistance was properly called by not only myself but also others here. TA after all is just a representation of supply and demand and resulting price which can be compared against historical outcomes. No guarantees but in my experience there are enough TA followers and programmed trading algorithms to make TA a factor to be considered.

GO ARMY BEAT NAVY!!!!!!